Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis

Summary

This study asks whether the multiple biological interactions of platelets can be transferred to an imaging nanoparticle for detecting atherosclerosis. Researchers coated a synthetic nanoparticle core with platelet membrane, creating a biomimetic carrier designed to recognize several features of plaque development rather than a single molecular target. In experimental assays, the coated particles interacted with activated vascular endothelium, foam cells, and exposed collagen, and these behaviors were attributed specifically to the platelet membrane layer. The particles localized not only to established plaques but also to arterial regions described as susceptible to future plaque formation. Incorporating a standard magnetic-resonance contrast agent enabled live imaging in an animal model of atherosclerosis. The principal finding is therefore a multivalent, biologically derived targeting surface that supports noninvasive visualization across different stages or components of vascular disease. This could provide mechanistic information beyond anatomic narrowing and potentially improve disease assessment. However, the evidence is preclinical. The abstract does not provide animal numbers, quantitative targeting or imaging accuracy, comparisons with standard imaging, biodistribution, clearance, toxicity, or longitudinal prediction of plaque events. Detection of “subclinical” susceptible regions is not shown to forecast disease in humans, and clinical manufacturing and safety remain untested.